MeSH tree: D02.626
A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional longer-term benefits.
Sep 21, 2024
0
187
Depression is one of the most common mental disorders, affecting an estimated 300 million people worldwide. While there are currently numerous pharmacological treatments for depression, how different treatments impact the ...
High doses of psilocybin—the active ingredient in magic mushrooms—appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram, suggests a systematic review ...
Aug 21, 2024
0
82
The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun".
Jul 5, 2024
0
435
About 1 in 5 people globally live with chronic pain, and it is a common reason for seeing a doctor, accounting for one in five GP appointments in the UK.
May 22, 2024
0
35
When a person is diagnosed with HIV, they are placed on a lifelong HIV treatment regimen, called antiretroviral therapy, to keep the virus under control. But for many people, having to take medicine every day can be a struggle ...
May 14, 2024
0
74
Magic mushrooms, LSD and other psychoactive compounds may help to improve sexual function for months after the psychedelic experience.
Feb 7, 2024
0
159
Research led by Queen Mary University of London's Wolfson Institute of Population Health has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently ...
Dec 6, 2023
0
49
A drug that can halve the risk of developing breast cancer in post-menopausal women has been approved for use in the UK. This drug, called anastrozole, could benefit an estimated 289,000 women in the UK who are at increased ...
Nov 9, 2023
0
56
The first-line pharmacological treatment for major depressive disorder (MDD) are antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). But a significant proportion of people don't respond to these ...
Oct 24, 2023
0
34
